{
  "id": 753,
  "text": "Six non-randomized studies730-735 were also identified.Iwasaka et al.730 compared the efficacy of adjuvant chemotherapy (combination of $5 0 ~ \\mathrm { m g }$ of cisplatin, $1 \\mathrm { m g }$ of vincristine, $8 ~ \\mathrm { m g / m } ^ { 2 }$ of mitomycin c, and $5 ~ \\mathrm { m g }$ of peplomycin) after radical hysterectomy with that of adjuvant radiotherapy (41-50 Gy).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Six non-randomized studies730-735 were also identified.Iwasaka et al.730 compared the efficacy of adjuvant chemotherapy (combination of $5 0 ~ \\mathrm { m g }$ of cisplatin, $1 \\mathrm { m g }$ of vincristine, $8 ~ \\mathrm { m g / m } ^ { 2 }$ of mitomycin c, and $5 ~ \\mathrm { m g }$ of peplomycin) after radical hysterectomy with that of adjuvant radiotherapy (41-50 Gy).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在评估子宫颈癌术后辅助化疗与辅助放疗的治疗效果时，需要考虑的具体化疗药物组合包括顺铂（cisplatin）、长春新碱（vincristine）、丝裂霉素C（mitomycin C）以及博来霉素（peplomycin）。这些药物组合常用于术后的辅助化疗，以提高治疗效果。通过与术后辅助放疗（如41-50 Gy的剂量）的对比，可以评估不同治疗方案的有效性和适应症。这些化疗药物的组合旨在最大限度减少癌症复发风险并提高患者的总体生存率。",
  "query": "评估子宫颈癌手术后辅助化疗与辅助放疗的治疗效果时，需要考虑哪些具体化疗药物的组合？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 评估子宫颈癌手术后辅助化疗与辅助放疗的治疗效果时，需要考虑哪些具体化疗药物的组合？\n\n<reference text>: Six non-randomized studies730-735 were also identified.Iwasaka et al.730 compared the efficacy of adjuvant chemotherapy (combination of $5 0 ~ \\mathrm { m g }$ of cisplatin, $1 \\mathrm { m g }$ of vincristine, $8 ~ \\mathrm { m g / m } ^ { 2 }$ of mitomycin c, and $5 ~ \\mathrm { m g }$ of peplomycin) after radical hysterectomy with that of adjuvant radiotherapy (41-50 Gy).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在评估子宫颈癌术后辅助化疗与辅助放疗的治疗效果时，需要考虑的具体化疗药物组合包括顺铂（cisplatin）、长春新碱（vincristine）、丝裂霉素C（mitomycin C）以及博来霉素（peplomycin）。这些药物组合常用于术后的辅助化疗，以提高治疗效果。通过与术后辅助放疗（如41-50 Gy的剂量）的对比，可以评估不同治疗方案的有效性和适应症。这些化疗药物的组合旨在最大限度减少癌症复发风险并提高患者的总体生存率。"
}